James Andrea S. 4
4 · Oncocyte Corp · Filed Dec 9, 2024
Insider Transaction Report
Form 4
James Andrea S.
Chief Financial Officer
Transactions
- Purchase
Common Stock, no par value
2024-12-05$2.29/sh+20,000$45,800→ 53,670 total
4 · Oncocyte Corp · Filed Dec 9, 2024
Common Stock, no par value